NCT01470937View on ClinicalTrials.gov

Early Diabetes Intervention Program

PHASE4CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Acarbose

acarbose 100 mg PO once daily

DRUG

Placebo

acarbose placebo

Trial Locations (1)

46202

Indiana University Hospital GCRC, Indianapolis

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Indiana University School of Medicine

OTHER

NCT01470937 - Early Diabetes Intervention Program | Biotech Hunter | Biotech Hunter